Synlab AG (LTS:0A9B) ROCE % : 7.61% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Synlab AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Synlab AG's annualized ROCE % for the quarter that ended in Mar. 2024 was 7.61%.

Synlab AG ROCE % Historical Data

The historical data trend for Synlab AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG ROCE % Chart

Synlab AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

6.79

20.89

7.61

5.85

Synlab AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial											6.62	5.23	17.77	-7.27	7.61

Synlab AG ROCE % Calculation

Synlab AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	250.738	/	( ( (5381.114 - 782.749)	+	(4663.266 - 682.853) )	/ 2 )
	=	250.738	/	( (4598.365	+	3980.413)	/ 2 )
	=	250.738	/	4289.389
	=	5.85 %

Synlab AG's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	304.068	/	( ( (4663.266 - 682.853)	+	(4707.237 - 693.852) )	/ 2 )
	=	304.068	/	( ( 3980.413	+	4013.385 )	/ 2 )
	=	304.068	/	3996.899
	=	7.61 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Synlab AG (LTS:0A9B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Synlab AG ROCE % Related Terms

Thank you for viewing the detailed overview of Synlab AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlab AG (LTS:0A9B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (LTS:0A9B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SYAB:Germany

Address

Moosacher Strasse 88, Augsburg, BY, DEU, 80809

Website

https://www.synlab.de

Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (LTS:0A9B) Headlines

No Headlines